Clinical Trial Update: The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism [Phase 4]

View source ↗

Summary

Clinical trial update reports the therapeutic effect of bromocriptine in patients with primary aldosteronism and associated hypertension (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aldosteronism
• Hypertension

Drugs mentioned

• Bromocriptine (bromocriptine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Hyperaldosteronism, Hypertension | Phase 4 | Status: UNKNOWN